Matthew Gline is the founder of Roivant Sciences. Roivant Sciences has raised $200M in total funding. Backed by QVT, NovaQuest Capital Management.
Matthew Gline is the Chief Executive Officer of Roivant Sciences, a company focused on biopharmaceutical research and development. In late 2023, Roivant Sciences engaged in a $7 billion deal with Roche, and Gline has indicated a focus on reinvesting this capital into R&D.
Full founder directory · Investor directory · Company funding database · Fundraising library